Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1,345,538
-
Shares change
-
+338,576
-
Total reported value, excl. options
-
$20,048,000
-
Value change
-
+$6,295,663
-
Number of buys
-
11
-
Number of sells
-
-10
-
Price
-
$14.90
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q4 2016
31 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share as of Q4 2016.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,345,538 shares
of 23,267,064 outstanding shares and own 5.8% of the company stock.
Largest 10 shareholders include Capital World Investors (435,000 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (350,000 shares), Rock Springs Capital Management LP (174,891 shares), ARMISTICE CAPITAL, LLC (124,000 shares), VANGUARD GROUP INC (88,917 shares), BAKER BROS. ADVISORS LP (57,762 shares), RENAISSANCE TECHNOLOGIES LLC (57,475 shares), GEODE CAPITAL MANAGEMENT, LLC (25,605 shares), BlackRock Institutional Trust Company, N.A. (11,195 shares), and Paloma Partners Management Co (10,781 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.